Screener
NeoGenomics NEO Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity | ||
| Common stock, $0.001 par value, (250,000,000 shares authorized; 130,301,168 and 128,989,152 shares issued, respectively; 127,917,946 and 128,989,152 shares outstanding, respectively) | $130 | $129 |
| Treasury stock, at cost, (2,383,222 and 0 shares, respectively) (Note 7) | (25,000) | — |
| Additional paid-in capital | 1,259,272 | 1,270,235 |
| Accumulated other comprehensive income | 4 | 4 |
| Accumulated deficit | (448,674) | (433,806) |
| Total stockholders' equity | $785,732 | $836,562 |
| Total liabilities and stockholders’ equity | $1,352,243 | $1,359,830 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's retained earnings?
- NeoGenomics (NEO) reported retained earnings of -$448.67M in Q2 2026.
- How has NeoGenomics's retained earnings changed year-over-year?
- NeoGenomics's retained earnings decreased by 13.1% year-over-year, from -$396.8M to -$448.67M.
- What is the long-term trend for NeoGenomics's retained earnings?
- Over 5 years (2020 to 2025), NeoGenomics's retained earnings has grown at a 127.1% compound annual growth rate (CAGR), from -$7.19M to -$433.81M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about NeoGenomics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude